These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21772793)

  • 1. Primary meningeal rhabdomyosarcoma.
    Palta M; Riedel RF; Vredenburgh JJ; Cummings TJ; Green S; Chang Z; Kirkpatrick JP
    Sarcoma; 2011; 2011():312802. PubMed ID: 21772793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803.
    Arndt CA; Stoner JA; Hawkins DS; Rodeberg DA; Hayes-Jordan AA; Paidas CN; Parham DM; Teot LA; Wharam MD; Breneman JC; Donaldson SS; Anderson JR; Meyer WH
    J Clin Oncol; 2009 Nov; 27(31):5182-8. PubMed ID: 19770373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhabdomyosarcoma: the experience of the pediatric unit of Kasr El-Aini Center of Radiation Oncology and Nuclear Medicine (NEMROCK) (from January 1992 to January 2001).
    Abd El-Aal HH; Habib EE; Mishrif MM
    J Egypt Natl Canc Inst; 2006 Mar; 18(1):51-60. PubMed ID: 17237856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venoocclusive disease of the liver after chemotherapy with vincristine, actinomycin D, and cyclophosphamide for the treatment of rhabdomyosarcoma. A report of the Intergroup Rhabdomyosarcoma Study Group. Childrens Cancer Group, the Pediatric Oncology Group, and the Pediatric Intergroup Statistical Center.
    Ortega JA; Donaldson SS; Ivy SP; Pappo A; Maurer HM
    Cancer; 1997 Jun; 79(12):2435-9. PubMed ID: 9191535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Paratesticular rhabdomyosarcoma: a case report].
    Chiba K; Kitami K; Kumagai H
    Hinyokika Kiyo; 1990 Mar; 36(3):363-6. PubMed ID: 2191575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rhabdomyosarcoma of the bladder: a case report].
    Kobayashi H; Kido K; Koie T; Ohyanagi H
    Gan To Kagaku Ryoho; 1996 Feb; 23(3):365-8. PubMed ID: 8712832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [PRIMARY PROSTATIC RHABDOMYOSARCOMA WITH REPEATING CEREBRAL HEMORRHAGE FROM BRAIN METASTASES IN AN ADULT: A CASE REPORT].
    Tochigi K; Sassa N; Kanada Y; Ohashi T; Inoue S; Takai S; Matsuo K; Majima T; Ishida S; Funahashi Y; Fujita T; Matsukawa Y; Kato M; Yamamoto T; Gotoh M
    Nihon Hinyokika Gakkai Zasshi; 2019; 110(2):119-123. PubMed ID: 32307379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of intensive therapy in children with localized alveolar extremity rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study.
    Heyn R; Beltangady M; Hays D; Lawrence W; Newton W; Crist W; Tefft M; Maurer HM
    J Clin Oncol; 1989 Feb; 7(2):200-7. PubMed ID: 2915235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleomorphic rhabdomyosarcoma with an impressive response to chemotherapy: case report and review of the literature.
    Kollár A; Langer R; Ionescu C; Cullmann JL; Klenke FM
    Tumori; 2016 Nov; 102(Suppl. 2):. PubMed ID: 26952562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An aggressive parameningeal rhabdomyosarcoma with multiple spinal cord metastases: a case report and review of the literature.
    Yavas G; Karabagli P; Paksoy Y; Yavas C; Karabagli H; Koksal Y
    Childs Nerv Syst; 2017 May; 33(5):843-847. PubMed ID: 27957633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment strategy and long-term outcomes of primary intracranial rhabdomyosarcoma: a single-institution experience and systematic review.
    Zheng JJ; Zhang GJ; Huo XL; Wang L; Hao SY; Zhang LW; Wu Z; Wu YM; Zhang JT; Li D
    J Neurosurg; 2020 Nov; 133(5):1302-1312. PubMed ID: 31518985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole abdominopelvic intensity-modulated radiation therapy for peritoneal disseminated rhabdomyosarcoma with three-year follow-up: a case report.
    Kawamura M; Okudaira K; Itoh Y; Kamomae T; Nishikawa E; Muramatsu H; Takahashi Y; Yokota K; Naganawa S
    Radiat Oncol; 2019 Jul; 14(1):127. PubMed ID: 31307511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary meningeal rhabdomyosarcoma in a child with hypomelanosis of Ito.
    Xu F; De Las Casas LE; Dobbs LJ
    Arch Pathol Lab Med; 2000 May; 124(5):762-5. PubMed ID: 10782165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic primary brain rhabdomyosarcoma in a pediatric patient: illustrative case.
    Mondragón-Soto MG; Del Valle L; González-Soto JA; De Leo-Vargas RA
    J Neurosurg Case Lessons; 2022 Jul; 4(4):CASE22189. PubMed ID: 36046269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: a report from the soft tissue sarcoma committee of the children's oncology group.
    Spunt SL; Smith LM; Ruymann FB; Qualman SJ; Donaldson SS; Rodeberg DA; Anderson JR; Crist WM; Link MP
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6072-9. PubMed ID: 15447992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case report of rhabdomyosarcoma of the uterus associated with uterine inversion.
    Case AS; Kirby TO; Conner MG; Huh WK
    Gynecol Oncol; 2005 Mar; 96(3):850-3. PubMed ID: 15721436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paratesticular rhabdomyosarcoma: results of therapy in 18 cases.
    Blyth B; Mandell J; Bauer SB; Colodny AH; Grier HE; Weinstein HJ; Tarbell NJ; Hendren WH; Retik AB
    J Urol; 1990 Dec; 144(6):1450-3. PubMed ID: 2122010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic options for primary meningeal angiosarcoma: A case report.
    Melguizo-Gavilanes I; Snipes G; Rodríguez-Márquez I; Duarte-Jurado L; Jaramillo-Jiménez E
    Surg Neurol Int; 2020; 11():204. PubMed ID: 32874707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local Control for Intermediate-Risk Rhabdomyosarcoma: Results From D9803 According to Histology, Group, Site, and Size: A Report From the Children's Oncology Group.
    Wolden SL; Lyden ER; Arndt CA; Hawkins DS; Anderson JR; Rodeberg DA; Morris CD; Donaldson SS
    Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1071-6. PubMed ID: 26581144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.
    Hawkins DS; Chi YY; Anderson JR; Tian J; Arndt CAS; Bomgaars L; Donaldson SS; Hayes-Jordan A; Mascarenhas L; McCarville MB; McCune JS; McCowage G; Million L; Morris CD; Parham DM; Rodeberg DA; Rudzinski ER; Shnorhavorian M; Spunt SL; Skapek SX; Teot LA; Wolden S; Yock TI; Meyer WH
    J Clin Oncol; 2018 Sep; 36(27):2770-2777. PubMed ID: 30091945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.